Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interleukin 6 Receptor Blockade for Relapse Prevention in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.

JAMA neurology·2026
Same author

Application of the 2024 McDonald Criteria in Individuals With Nonspecific Symptoms or Incidental Imaging Findings in a Multicenter Study.

Neurology·2026
Same author

High-dose <i>N</i>-acetyl cysteine reduces GFAP levels: Exploratory results from a pilot double-blind, placebo-controlled randomized trial.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Adenotonsillectomy is associated with increased risk and disease activity in pediatric-onset multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

The gut microbiome in pediatric-onset acquired demyelinating syndromes by myelin oligodendrocyte glycoprotein antibody status.

Multiple sclerosis and related disorders·2026
Same author

Higher ultra-processed food consumption is associated with higher likelihood of paediatric-onset multiple sclerosis.

Multiple sclerosis and related disorders·2026

Related Experiment Video

Updated: Jun 24, 2026

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

Pediatric multiple sclerosis.

Emmanuelle Waubant1, Dorothee Chabas

  • 1Emmanuelle Waubant, MD, PhD University of California San Francisco, Regional Pediatric Multiple Sclerosis Center, 350 Parnassus Avenue, Suite 908, San Francisco, CA 94117, USA. emmanuelle.waubant@ucsf.edu.

Current Treatment Options in Neurology
|April 15, 2009
PubMed
Summary

Diagnosing pediatric multiple sclerosis (MS) is difficult due to unique early symptoms and imaging findings. Current treatments for adults are used off-label, with some children requiring second-line therapies.

More Related Videos

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

Repeated Transcranial Magnetic Stimulation Combined with Action Observation Training in Children with Spastic Cerebral Palsy
07:20

Repeated Transcranial Magnetic Stimulation Combined with Action Observation Training in Children with Spastic Cerebral Palsy

Published on: August 9, 2024

Related Experiment Videos

Last Updated: Jun 24, 2026

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

Repeated Transcranial Magnetic Stimulation Combined with Action Observation Training in Children with Spastic Cerebral Palsy
07:20

Repeated Transcranial Magnetic Stimulation Combined with Action Observation Training in Children with Spastic Cerebral Palsy

Published on: August 9, 2024

Area of Science:

  • Pediatric Neurology
  • Neuroimmunology
  • Clinical Diagnosis

Background:

  • Pediatric multiple sclerosis (MS) diagnosis presents unique challenges compared to adult-onset MS.
  • Limited diagnostic criteria and overlap with acute disseminated encephalomyelitis complicate early identification.
  • Early age of onset is associated with distinct clinical and radiological features.

Purpose of the Study:

  • To highlight the diagnostic challenges in pediatric MS.
  • To describe specific features of early-onset MS in children.
  • To discuss therapeutic considerations for pediatric MS.

Main Methods:

  • Review of clinical presentation in pediatric MS.
  • Analysis of neuroimaging findings (MRI) in young patients.
  • Evaluation of cerebrospinal fluid (CSF) biomarkers.
  • Assessment of treatment responses to adult-approved MS therapies.

Main Results:

  • Pediatric MS often presents with encephalopathy, seizures, and brainstem/cerebellar symptoms.
  • Initial MRI may show posterior fossa involvement and transient T2-bright lesions.
  • CSF analysis may lack oligoclonal bands or elevated IgG index in children.
  • Some children experience disease breakthrough on first-line adult therapies.

Conclusions:

  • Pediatric MS diagnosis requires careful consideration of specific early-onset features.
  • Current therapeutic strategies involve off-label use of adult MS drugs.
  • Second-line therapies may be necessary for children with treatment-resistant pediatric MS.